Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer.
131I continues to be one of the safest and most effective methods of diagnosing and treating metastatic well differentiated thyroid cancer. It is not without risk, however, and must be judiciously applied to carefully prepared and selected patients.
Maxon
H R
HR
Department of Radiology, University of Cincinnati Hospital, Ohio.
Smith
H S
HS
D000230:Adenocarcinoma / Q000175:diagnosis / Q000532:radiotherapy; D000277:Adjuvants, Pharmaceutic; D001842:Bone and Bones / Q000187:drug effects; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000532:radiotherapy; D006066:Gonads / Q000187:drug effects; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects; D008094:Lithium / Q000494:pharmacology; D008207:Lymphatic Metastasis / Q000175:diagnosis; D009362:Neoplasm Metastasis / Q000175:diagnosis; D009364:Neoplasm Recurrence, Local; D011014:Pneumonia / Q000209:etiology; D012469:Salivary Glands / Q000187:drug effects; D013961:Thyroid Gland / Q000187:drug effects; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000532:radiotherapy; D014827:Vocal Cords / Q000187:drug effects
D000277:Adjuvants, Pharmaceutic; D007457:Iodine Radioisotopes; D008094:Lithium